Safety of a trivalent live attenuated intranasal influenza vaccine, FluMist(TM), administered in addition to parenteral trivalent inactivated influenza vaccine to seniors with chronic medical conditions

Vaccine

Volumn 17, Issue 15-16, 1999, Pages 1905-1909

  Jackson, Lisa A ^a   Holmes, Sandra J ^b   Mendelman, Paul M ^b   Huggins, Linda ^d   Cho, Iksung ^b   Rhorer, Janelle ^c  

^a UNIVERSITY OF WASHINGTON   (United States)

^b MEDIMMUNE   (United States)

^c University of Iowa   (United States)

^d NONE

Author keywords

Influenza vaccine; Vaccine safety

Indexed keywords

INFLUENZA VACCINE; LIVE VACCINE; PLACEBO; UNCLASSIFIED DRUG; VIRUS VACCINE;

AGED; ARTICLE; CHRONIC DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG FORMULATION; DRUG SAFETY; FEMALE; GERIATRIC PATIENT; HUMAN; INFLUENZA; INFLUENZA VACCINATION; INFLUENZA VIRUS; INTRANASAL DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT INFECTION; SORE THROAT; SYRINGE; TREATMENT OUTCOME; VIRUS INFECTION;

ADMINISTRATION, INTRANASAL; AGED; BODY TEMPERATURE; CARDIOVASCULAR DISEASES; CHRONIC DISEASE; DIABETES MELLITUS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INFLUENZA VACCINES; INJECTIONS; LUNG DISEASES; MALE; PHARYNGITIS; PROSPECTIVE STUDIES; TIME FACTORS; VACCINATION; VACCINES, ATTENUATED; VACCINES, INACTIVATED;

EID: 0033537856     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(98)00471-X     Document Type: Article

References (15)

1. Nichol K.L., Margoli K.L., Wuorenma J., Von Sternberg T. The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community. N. Engl. J. Med. 331:1994;778-784.
2. Fedson D.S., Wajda A., Nicol J.P., Hammond G.W., Kaiser D.L., Roos L.L. Clinical effectiveness of influenza vaccination in Manitoba. JAMA. 270:1993;1956-1961.
3. Govaert Th.M.E., Thijs C.T.M.C.N., Masurel N., Sprenger M.J.W., Dinant G.J., Knottnerus J.A. The efficacy of influenza vaccination in elderly individuals. JAMA. 272:1994;1661-1665.
4. Patriarca P.A., Weber J.A., Parker R.A., Hall W.N., Kendal A.P., Bregman D.J., Schonberger L.B. Efficacy of influenza vaccine in nursing homes. JAMA. 253:1985;1136-1139.
5. CDC Update: influenza activity, United States, 1997-1998 season. M.M.W.R. 47:1998;196-200.
6. Belshe R.B., Van Voris L.P. Cold-recombinant influenza A/California/10/78 (H1N1) virus vaccine (CR-37) in seronegative children: infectivity and efficacy against investigational challenge. J. Infect. Dis. 149:1984;735-740.
7. Treanor J.J., Mattison H.R., Dumyati G., Yinnon A., Erb S., O'Brien D., Dolin R., Betts R.F. Protective efficacy of combined live intranasal and inactivated influenza A virus vaccines in the elderly. Ann. Int. Med. 117:1992;625-633.
8. Edwards K.M., Dupont W.D., Westrich M.K., Plummer W.D., Palmer P.S., Wright P.F. A randomized controlled trial of cold-adapted and inactivated vaccines for the prevention of influenza A disease. J. Infect. Dis. 169:1994;68-76.
9. Edwards K.M., King J.C., Steinhoff M.C., Thompson J., Clements M.L., Wright P.F., Murphy B.R. Safety and immunogenicity of live attenuated cold-adapted influenza B/Ann Arbor/1/85 reassortant virus vaccine in infants and children. J. Infect. Dis. 163:1991;740-745.
10. Treanor J.J., Dumyati G., O'Brien D., Riley M., Riley G., Erb S., Betts R. Evaluation of cold-adapted, reassortant influenza B virus in elderly and chronically ill adults. J. Infect. Dis. 169:1993;402-407.
11. Belshe R.B., Mendelman P.M., Treanor J., King J., Gruber W.C., Piedra P., Bernstein D.I., Hayden F.G., Kotloff K., Zangwill K., Iacuzio D., Wolff M. The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine in children. N. Engl. J. Med. 338:1998;1405-1412.
12. Maassab H.F., Heilman C.A., Herlocher M.L. Cold-adapted influenza viruses for use as live vaccines for man. Adv. Biotechnol. Proc. 14:1990;203-242.
13. Belshe R.B. A review of attenuation of influenza viruses by genetic manipulation. Am. J. Resp. Crit. Care Med. 152:1995;S72-5.
14. Gorse G.J., Campbell M.J., Otto E.E., Powers D.C., Chambers G.W., Newman F.K. Increased anti-influenza A virus cytotoxic T-cell activity following vaccination of the chronically ill elderly with live attenuated or inactivated influenza virus vaccine. J. Infect. Dis. 172:1995;1-10.
15. Gorse G.J., Otto E.E., Powers D.C., Chambers G.W., Eickhoff C.S., Newman F.K. Induction of mucosal antibodies by live attenuated and inactivated influenza virus vaccines in the chronically ill elderly. J. Infect. Dis. 173:1996;285-290.